Drug Treatment for TB Meningitis

Initial Treatment Regimen

• The American Thoracic Society recommends an initial intensive phase of 2 months with isoniazid, rifampicin, pyrazinamide, and a fourth drug, either ethambutol or streptomycin, for the treatment of TB meningitis 3, 4, 5, 6
• The treatment should be followed by a continuation phase of 7-10 months with isoniazid and rifampicin, for a total treatment duration of 9-12 months 1, 6

Drug Penetration Considerations

• Isoniazid, pyrazinamide, and ethionamide penetrate well into the cerebrospinal fluid, while rifampicin penetrates less well but remains essential for treatment 1
• Streptomycin and ethambutol only penetrate adequately when meninges are inflamed in early treatment stages 1

Adjunctive Corticosteroid Therapy

• The Infectious Diseases Society of America strongly recommends adjunctive corticosteroid therapy with dexamethasone or prednisolone tapered over 6-8 weeks for the treatment of TB meningitis 3, 5, 6
• Corticosteroids have been shown to reduce mortality in TB meningitis 4, 6

Special Populations

• For children with TB meningitis, the Centers for Disease Control and Prevention recommends an initial 4-drug regimen of INH, RIF, PZA, and ethionamide or an aminoglycoside for 2 months, followed by 7-10 months of INH and RIF 3, 4, 5

Monitoring and Follow-up

• Regular clinical assessment for neurological improvement or deterioration is recommended 2
• Repeated lumbar punctures should be considered to monitor changes in cerebrospinal fluid cell count, glucose, and protein, especially early in the course of therapy 3, 6

Complications and Management

• Hydrocephalus is a complication of tuberculous meningitis that may require neurosurgical referral 3
• Clinical situations with paraparesis may also require neurosurgical referral 6

Common Pitfalls to Avoid

• Inadequate treatment duration is a common pitfall, as TB meningitis requires longer treatment than pulmonary TB 2
• Insufficient drug penetration into CSF is another common pitfall, and appropriate drug selection is essential 1

Emerging Research

• Higher doses of intravenous rifampicin and fluoroquinolones are being evaluated in adults with tuberculous meningitis 6